| Income Statement |
| Operating Expenses | 4.59M |
|
| Research and Development Expense | 862.00K |
| Selling, General and Administrative Expense | 3.54M |
| Operating Income | -4.59M |
| Net Income | -4.67M |
| Net Income Common Stock | -4.67M |
| Net Income Common Stock (USD) | -4.67M |
| Consolidated Income | -4.67M |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -4.67M |
| Earning Before Interest & Taxes (USD) | -4.67M |
| Weighted Average Shares | 122.57M |
| Weighted Average Shares Diluted | 122.57M |
| Balance Sheet |
| Cash and Equivalents | 41.46M |
| Cash and Equivalents (USD) | 41.46M |
| Current Assets | 42.35M |
| Property, Plant & Equipment Net | 144.43M |
| Total Assets | 189.13M |
| Debt Current | 3.71M |
| Total Debt | 3.71M |
| Current Liabilities | 9.06M |
| Total Liabilities | 10.44M |
| Accumulated Retained Earnings (Deficit) | -405.69M |
| Shareholders Equity | 178.70M |
| Shareholders Equity (USD) | 178.70M |
| Assets Non-Current | 146.79M |
| Total Debt (USD) | 3.71M |
| Liabilities Non-Current | 1.38M |
| Trade and Non-Trade Payables | 4.41M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 277.00K |
| Net Cash Flow from Financing | -1.52M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.11M |
| Capital Expenditure | -1.55M |
| Issuance (Purchase) of Equity Shares | 1.21M |
| Issuance (Repayment) of Debt Securities | -1000 |
| Net Cash Flow from Investing | -1.55M |
| Net Cash Flow from Operations | -4.04M |
| Share Based Compensation | 623.00K |